223 related articles for article (PubMed ID: 34534363)
1. Serum beta-secretase 1 (BACE1) activity increases in patients with mild cognitive impairment.
Zuliani G; Trentini A; Brombo G; Rosta V; Guasti P; Romagnoli T; Polastri M; Marabini L; Pedrini D; Pistolesi C; Pacifico S; Guerrini R; Seripa D; Cervellati C
J Neurochem; 2021 Nov; 159(3):629-637. PubMed ID: 34534363
[TBL] [Abstract][Full Text] [Related]
2. Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.
Shen Y; Wang H; Sun Q; Yao H; Keegan AP; Mullan M; Wilson J; Lista S; Leyhe T; Laske C; Rujescu D; Levey A; Wallin A; Blennow K; Li R; Hampel H
Biol Psychiatry; 2018 Mar; 83(5):447-455. PubMed ID: 28359566
[TBL] [Abstract][Full Text] [Related]
3. The feasibility of utilizing plasma MiRNA107 and BACE1 messenger RNA gene expression for clinical diagnosis of amnestic mild cognitive impairment.
Wang T; Chen K; Li H; Dong S; Su N; Liu Y; Cheng Y; Dai J; Yang C; Xiao S
J Clin Psychiatry; 2015 Feb; 76(2):135-41. PubMed ID: 25742200
[TBL] [Abstract][Full Text] [Related]
4. Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.
Coutinho AM; Porto FH; Duran FL; Prando S; Ono CR; Feitosa EA; Spíndola L; de Oliveira MO; do Vale PH; Gomes HR; Nitrini R; Brucki SM; Buchpiguel CA
Alzheimers Res Ther; 2015 Sep; 7(1):58. PubMed ID: 26373380
[TBL] [Abstract][Full Text] [Related]
5. High plasma homocysteine levels predict the progression from mild cognitive impairment to dementia.
Zuliani G; Brombo G; Polastri M; Romagnoli T; Mola G; Riccetti R; Seripa D; Trentini A; Cervellati C
Neurochem Int; 2024 Jul; 177():105763. PubMed ID: 38723899
[TBL] [Abstract][Full Text] [Related]
6. Processing of the platelet amyloid precursor protein in the mild cognitive impairment (MCI).
Bermejo-Bescós P; Martín-Aragón S; Jiménez-Aliaga K; Benedí J; Felici E; Gil P; Ribera JM; Villar AM
Neurochem Res; 2013 Jul; 38(7):1415-23. PubMed ID: 23575575
[TBL] [Abstract][Full Text] [Related]
7. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
[TBL] [Abstract][Full Text] [Related]
8. Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease.
Zuliani G; Trentini A; Rosta V; Guerrini R; Pacifico S; Bonazzi S; Guiotto A; Passaro A; Seripa D; Valacchi G; Cervellati C
Sci Rep; 2020 Sep; 10(1):14980. PubMed ID: 32917964
[TBL] [Abstract][Full Text] [Related]
9. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.
Vos SJ; van Rossum IA; Verhey F; Knol DL; Soininen H; Wahlund LO; Hampel H; Tsolaki M; Minthon L; Frisoni GB; Froelich L; Nobili F; van der Flier W; Blennow K; Wolz R; Scheltens P; Visser PJ
Neurology; 2013 Mar; 80(12):1124-32. PubMed ID: 23446677
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson's disease.
Chung SJ; Park YH; Yun HJ; Kwon H; Yoo HS; Sohn YH; Lee JM; Lee PH
Eur J Neurol; 2019 May; 26(5):766-773. PubMed ID: 30565368
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-Independent Amnestic Mild Cognitive Impairment and Serum Apolipoprotein A1 Levels.
Choi HJ; Seo EH; Yi D; Sohn BK; Choe YM; Byun MS; Lee JM; Woo JI; Lee DY
Am J Geriatr Psychiatry; 2016 Feb; 24(2):144-53. PubMed ID: 26238231
[TBL] [Abstract][Full Text] [Related]
13. Increased Serum Beta-Secretase 1 Activity is an Early Marker of Alzheimer's Disease.
Nicsanu R; Cervellati C; Benussi L; Squitti R; Zanardini R; Rosta V; Trentini A; Ferrari C; Saraceno C; Longobardi A; Bellini S; Binetti G; Zanetti O; Zuliani G; Ghidoni R
J Alzheimers Dis; 2022; 87(1):433-441. PubMed ID: 35275540
[TBL] [Abstract][Full Text] [Related]
14. Serum beta-secretase 1 (BACE1) activity as candidate biomarker for late-onset Alzheimer's disease.
Cervellati C; Trentini A; Rosta V; Passaro A; Bosi C; Sanz JM; Bonazzi S; Pacifico S; Seripa D; Valacchi G; Guerini R; Zuliani G
Geroscience; 2020 Feb; 42(1):159-167. PubMed ID: 31745860
[TBL] [Abstract][Full Text] [Related]
15. Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment.
Zhong Z; Ewers M; Teipel S; Bürger K; Wallin A; Blennow K; He P; McAllister C; Hampel H; Shen Y
Arch Gen Psychiatry; 2007 Jun; 64(6):718-26. PubMed ID: 17548753
[TBL] [Abstract][Full Text] [Related]
16. Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease.
Zetterberg H; Andreasson U; Hansson O; Wu G; Sankaranarayanan S; Andersson ME; Buchhave P; Londos E; Umek RM; Minthon L; Simon AJ; Blennow K
Arch Neurol; 2008 Aug; 65(8):1102-7. PubMed ID: 18695061
[TBL] [Abstract][Full Text] [Related]
17. Structural Brain Volume Covariance Associated with Gait Speed in Patients with Amnestic and Non-Amnestic Mild Cognitive Impairment: A Double Dissociation.
Allali G; Montembeault M; Saj A; Wong CH; Cooper-Brown LA; Bherer L; Beauchet O
J Alzheimers Dis; 2019; 71(s1):S29-S39. PubMed ID: 31127784
[TBL] [Abstract][Full Text] [Related]
18. Predictors of independence in instrumental activities of daily living: Amnestic versus nonamnestic MCI.
Putcha D; Tremont G
J Clin Exp Neuropsychol; 2016 Nov; 38(9):991-1004. PubMed ID: 27240585
[TBL] [Abstract][Full Text] [Related]
19. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
[TBL] [Abstract][Full Text] [Related]
20. High activities of BACE1 in brains with mild cognitive impairment.
Cheng X; He P; Lee T; Yao H; Li R; Shen Y
Am J Pathol; 2014 Jan; 184(1):141-7. PubMed ID: 24332014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
